Patent Applications published on Jun 12, 2025 - page 4

#901
US20250186427A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING VASOMOTOR SYMPTOMS

#902
US20250186428A1
Human necessities

BUPROPION DOSAGE FORMS WITH REDUCED FOOD AND ALCOHOL DOSING EFFECTS

#903
US20250186429A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING TACTILE DYSFUNCTION AND ANXIETY ASSOCIATED WITH AUTISM SPECTRUM DISORDER, RETT SYNDROME, AND FRAGILE X SYNDROME

#904
US20250186430A1
Human necessities

THERAPY OF INTEROCEPTION DISORDERS WITH CGRP RECEPTOR ANTAGONISTS

#905
US20250186431A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR RADIOTHERAPY, AND METHOD FOR TREATING SOLID CANCER USING SAME

#906
US20250186432A1
Human necessities

SPLEEN TYROSINE KINASE INHIBITOR, COMPOSITION, AND METHODS OF USE

#907
US20250186433A1
Human necessities

ACSS2 INHIBITORS AND METHODS OF USE THEREOF

#908
US20250186434A1
Human necessities

SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS

#909
US20250186435A1
Human necessities

PHARMACEUTICAL FORMULATIONS AND THEIR PREPARATIONS FOR TREATMENT OF CANCER

#910
US20250186436A1
Human necessities

SPIROCYCLIC PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE

#911
US20250186437A1
Human necessities

CARBOLINE COMPOUNDS AND USE THEREOF

#912
US20250186438A1
Human necessities

TREATMENT OF CLEAR CELL RENAL CELL CARCINOMA

#913
US20250186439A1
Human necessities

PYK2 INHIBITION MODULATES IMMUNE CELL FUNCTION

#914
US20250186440A1
Human necessities

USE OF ANDROGEN RECEPTOR DEGRADER FOR THE TREATMENT OF SPINAL AND BULBAR MUSCULAR ATROPHY

#915
US20250186441A1
Human necessities

COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES

#916
US20250186442A1
Human necessities

Obicetrapib and Ezetimibe Combination Treatment and Fixed Dose Pharmaceutical Compositions

#917
US20250186443A1
Human necessities

VALACYCLOVIR AND CELECOXIB IN COMBINATION WITH NIRMATRELVIR AND RITONAVIR FOR THE TREATMENT OF COVID-19

#918
US20250186444A1
Human necessities

METHIONINE ADENOSYLTRANSFERASE 2A HETEROCYCLIC INHIBITOR

#919
US20250186445A1
Human necessities

TREATMENT OF CANCER WITH MENIN INHIBITORS AND IMMUNO-ONCOLOGY AGENTS

#920
US20250186446A1
Human necessities

ORGANIC COMPOUNDS

#921
US20250186447A1
Human necessities

WEE1 KINASE INHIBITORS AND METHODS OF TREATING CANCER USING THE SAME

#922
US20250186448A1
Human necessities

FORMULATIONS OF UDENAFIL

#923
US20250186449A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING A V-ATPASE MALFUNCTION

#924
US20250186450A1
Human necessities

COMBINATION THERAPY COMPRISING DGK INHIBITORS and PD-1/PD-L1 INHIBITORS

#925
US20250186451A1
Human necessities

METHODS OF TREATING CANCER WITH IAP ANTAGONIST COMPOUNDS AND COMBINATION THERAPIES

#926
US20250186452A1
Human necessities

NOVEL USE OF QUINOLINE COMPOUND

#927
US20250186453A1
Human necessities

COMBINATION THERAPIES COMPRISING A SOS1 INHIBITOR AND A MEK INHIBITOR

#928
US20250186454A1
Human necessities

METHODS FOR TREATING ABERRANT BEHAVIOR AND MOTOR ACTIVITY

#929
US20250186455A1
Human necessities

TREATMENT COMPOSITION FOR TREATING CHRONIC PAIN AND MIXED PAIN SITES

#930
US20250186456A1
Human necessities

PYRIMIDINE-FUSED CYCLIC COMPOUND AND PREPARATION METHOD AND USE THEREOF

#931
US20250186457A1
Human necessities

USE OF AN ORGANOMETALLIC RUTHENIUM COMPOUND FOR THE PREVENTION AND/OR TREATMENT OF DISEASES AND/OR CONDITIONS RELATED TO CANCER IN AN INDIVIDUAL

#932
US20250186458A1
Human necessities

METHODS FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT

#933
US20250186459A1
Human necessities

NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS

#934
US20250186460A1
Human necessities

TREATMENT PARADIGM FOR AN ANTI-CD19 ANTIBODY AND VENETOCLAX COMBINATION TREATMENT

#935
US20250186461A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING HERNIAS

#936
US20250186462A1
Human necessities

COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER

#937
US20250186463A1
Human necessities

ABIRATERONE DECANOATE PRODRUGS AND USE IN THERAPY

#938
US20250186464A1
Human necessities

METHODS OF TREATING VITAMIN D INSUFFICIENCY IN CHRONIC KIDNEY DISEASE

#939
US20250186465A1
Human necessities

9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USE THEREOF IN TREATING COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP)

#940
US20250186466A1
Human necessities

ZLT-007 AND METHODS OF TREATING DIABETIC NEUROPATHY

#941
US20250186467A1
Human necessities

METHODS OF TREATING MEDICAL CONDITIONS USING STAMPIDINE OR A RELATED COMPOUND

#942
US20250186468A1
Human necessities

METHOD FOR TREATING PATIENT WITH BRCA-MUTATED CANCER

#943
US20250186469A1
Human necessities

THERAPEUTIC AGENT FOR OVARIAN CLEAR CELL CARCINOMA

#944
US20250186470A1
Human necessities

Compositions and Methods Using Lactulose for Treating Disease

#945
US20250186471A1
Human necessities

USE OF OLEANOLIC ACID-28-O-BETA-D-GLUCOPYRANOSIDE IN PREPARATION OF ANTI-COLITIS DRUG

#946
US20250186472A1
Human necessities

COMBINATION OF POH AND REMDESIVIR FOR TREATMENT OF CNS INFECTIONS

#947
US20250186473A1
Human necessities

Compositions and Methods for Treating Kidney Disease

#948
US20250186474A1
Human necessities

PHARMACEUTICAL SOLUTION COMPOSITION AND ORAL MIST INHALER COMPRISING THE SAME

#949
US20250186475A1
Human necessities

METHODS OF TREATING MEDICAL CONDITIONS USING ISLATRAVIR OR A RELATED COMPOUND

#950
US20250186476A1
Human necessities

Compositions Containing Adenosine Triphosphate (ATP) and Methods of Use

#951
US20250186477A1
Human necessities

COMPOSITIONS COMPRISING FLUDARABINE PHOSPHATE AND METHODS OF MAKING AND USING SAME TO TREAT CANCER

#952
US20250186478A1
Human necessities

METHODS AND COMPOSITIONS FOR TARGETED GENE TRANSFER

#953
US20250186479A1
Human necessities

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

#954
US20250186480A1
Human necessities

Treatment Methods for Fibrosis Targeting SMOC2

#955
US20250186481A1
Human necessities

Multi fiber composition with improved fermentation

#956 ✅ Patent 12,343,358 granted on 2025-07-01
US20250186482A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#957
US20250186483A1
Human necessities

METHODS AND COMPOSITIONS FOR PROMOTING COGNITIVE FUNCTIONING

#958
US20250186484A1
Human necessities

Methods of administering safe colon cleansing compositions

#959
US20250186485A1
Human necessities

HYDRATION COMPOSITIONS

#960
US20250186486A1
Human necessities

POTENTIATION OF DURABLE ANTITUMOR IMMUNITY BY MULTIFACTORIAL IMMUNE MODULATION

#961
US20250186487A1
Human necessities

ORALLY SAFE BINDING SYSTEMS FOR TREATING DISEASE

#962 ✅ Patent 12,364,713 granted on 2025-07-22
US20250186488A1
Human necessities

COAGULATION MOLD, A KIT AND A METHOD FOR PREPARING A COAGULATED BLOOD MASS

#963
US20250186489A1
Human necessities

REPROGRAMMING OF CELLS TO TYPE 1 CONVENTIONAL DENDRITIC CELLS OR ANTIGEN-PRESENTING CELLS

#964
US20250186490A1
Human necessities

METHOD OF CHEMICALLY TREATING OR CULTIVATING MACROPHAGES AND THEIR THERAPEUTIC APPLICATIONS IN FIBROTIC DISEASES

#965
US20250186491A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH CHIMERIC TIM RECEPTORS IN COMBINATION WITH INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE

#966
US20250186492A1
Human necessities

CAR-T CELL TARGETING B7-H3 AND APPLICATION THEREOF IN TREATMENT OF ACUTE MYELOID LEUKEMIA

#967
US20250186493A1
Human necessities

ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS

#968
US20250186494A1
Human necessities

CAR-T THERAPIES TARGETED VIA COVALENTLY BONDED ADAPTERS

#969
US20250186495A1
Human necessities

PD-L1-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELL COMPRISING SAME

#970
US20250186496A1
Human necessities

METHODS AND COMPOSITIONS FOR CONTROLLING T CELL ACTIVATION

#971
US20250186497A1
Human necessities

STABLE REGULATORY T CELLS AND METHODS OF PRODUCTION

#972
US20250186498A1
Human necessities

COMPOSITION FOR HEARING LOSS MITIGATION AND USE THEREOF

#973
US20250186499A1
Human necessities

USE OF A PURIFIED EXOSOME DRY POWDER FOR RELIEVING INFLAMMATION OR INJURY

#974
US20250186500A1
Human necessities

USE OF A PURIFIED PLATELET-DERIVED EXOSOME DRY POWDER FOR RELIEVING INFLAMMATION OR INJURY

#975
US20250186501A1
Human necessities

PREPARATIONS COMPRISING MESENCHYMAL STEM CELLS AND CANNABINOIDS AND METHODS OF THEIR USE

#976
US20250186502A1
Human necessities

System and Methods for Preparation of Adipose-Derived Stem Cells

#977
US20250186503A1
Human necessities

METHODS AND COMBINATIONS FOR TREATMENT AND T CELL MODULATION

#978
US20250186504A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR ALLEVIATION OR TREATMENT OF CEREBRAL INFARCTION SEQUELA

#979
US20250186505A1
Human necessities

Methods of Determining the Suitability of Cultured Thymus Tissue for Implantation Into Humans and Associated Methods of Use

#980
US20250186506A1
Human necessities

HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE

#981
US20250186507A1
Human necessities

METHOD FOR PREPARING HUMAN PLURIPOTENT STEM CELL-DERIVED LEYDIG-LIKE CELLS, AND HUMAN PLURIPOTENT STEM CELL-DERIVED LEYDIG-LIKE CELL POPULATION

#982
US20250186508A1
Human necessities

PAR2 MODULATION TO ALTER MYELINATION

#983
US20250186509A1
Human necessities

Treatment for Chronic Kidney Disease

#984
US20250186510A1
Human necessities

BACTERIAL COMPOSITION FOR USE IN TREATMENT OF SUBSTANCE USE DISORDER

#985
US20250186511A1
Human necessities

PARACOCCUS AMINOVORANS BM109 STRAIN AND USES THEREOF

#986
US20250186512A1
Human necessities

LIVE MYCOPLASMA SYNOVIAE VACCINE

#987
US20250186513A1
Human necessities

METHANOGENS AND PREVOTELLA AS MICROBIAL CONVENER FOR THE TREATMENT OF DISEASES AND DIAGNOSIS THEREOF

#988
US20250186514A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE UROGENITAL SYSTEM

#989
US20250186515A1
Human necessities

PROBIOTIC COMPOSITIONS AND METHODS

#990
US20250186516A1
Human necessities

LIGILACTOBACILLUS PROBIOTICS, LIGILACTOBACILLUS EXTRACELLULAR VESICLES AND METHODS OF USING SAME

#991
US20250186517A1
Human necessities

METHOD OF TREATMENT

#992
US20250186518A1
Human necessities

PROBIOTIC COMPOSITION FOR IMPROVING SOY PROTEIN PROTEOLYSIS AND AMINO ACID PRODUCTION ACTIVITY

#993
US20250186519A1
Human necessities

USE OF A PROBIOTIC COMPOSITION IN A METHOD OF TREATMENT OF MANIFESTATIONS OF SELF-REPORTED MENTAL EXHAUSTION, PREFERABLY WITH MANIFESTATIONS OF LOW ENERGY LEVELS

#994
US20250186520A1
Human necessities

ONCOLYTIC VIRUS COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

#995
US20250186521A1
Human necessities

ALGAL FEED INGREDIENT FOR CONTROLLING THE EFFECTS OF COCCIDIOSIS AND NECROTIC ENTERITIS IN POULTRY

#996
US20250186522A1
Human necessities

COMPOSITIONS AND METHODS FOR PROMOTING A HEALTHY MICROBIAL FLORA IN A MAMMAL

#997
US20250186523A1
Human necessities

APPLICATION OF FRUITING BODY OF LYOPHYLLUM DECASTES IN PREPARING LYOPHYLLUM DECASTES FOOD OR LIPID-LOWERING DRUGS

#998
US20250186524A1
Human necessities

SYNTHESIS OF A CARBON QUANTUM DOTS AND SILVER NANOPARTICLE COMPOSITION

#999
US20250186525A1
Human necessities

DECAFFEINATED YERBA MATE EXTRACT, ANTI-OBESITY COMPOSITION, DECAFFEINATION METHOD AND METHOD FOR THE PRODUCTION OF A YERBA MATE EXTRACT

#1000
US20250186526A1
Human necessities

HEALING CREAMS AND FORMULATIONS CONTAINING POMEGRANATE SEED OIL, ROSA CANINA FRUIT OIL, INULA VISCOSA OLEORESIN OR EXTRACT AND OPTIONALLY CITRUS MEDICA VULGARIS ETROG OIL OR EXTRACT

#1001
US20250186527A1
Human necessities

METHODS OF TREATING ENDOMETRIAL CANCER USING HEMP EXTRACT

#1002
US20250186528A1
Human necessities

ANTI-OBESITY AGENT AND ANTI-OBESITY COMPOSITION

#1003
US20250186529A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR MANAGING DYSMENORRHEA

#1004
US20250186530A1
Human necessities

USE OF EFFECTIVE PART EXTRACT OF MONOCHASMA SAVATIERI IN PREPARATION OF DRUG FOR TREATING INFLAMMATORY DISEASE OR TUMOR

#1005
US20250186531A1
Human necessities

BOYSENBERRY, APPLE, AND BLACKCURRANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR

#1006
US20250186532A1
Human necessities

SHINE MUSCAT JELLY HAVING HIGH SENSORY APPEAL AND EXCELLENT ANTIOXIDANT AND ANTITHROMBOTIC ACTIVITIES, AND METHOD OF PREPARING SAME

#1007
US20250186533A1
Human necessities

LISINOPRIL FORMULATIONS

#1008
US20250186534A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING THROMBOLYTIC PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATE

#1009
US20250186535A1
Human necessities

OPHTALMIC COMPOSITIONS AND METHODS OF USING SAME

#1010
US20250186536A1
Human necessities

SUSTAINED RELEASE PEPTIDE FORMULATIONS

#1011
US20250186537A1
Human necessities

TREATMENT OF WOMEN AFFECTED WITH POLYCYSTIC OVARY SYNDROME

#1012
US20250186538A1
Human necessities

BIVALIRUDIN COMPOUNDS

#1013
US20250186539A2
Human necessities

METHODS FOR TREATING CANCER

#1014
US20250186540A1
Human necessities

VIPR2 ANTAGONIST PEPTIDE FOR SUPPRESSING CANCER METASTASIS

#1015
US20250186541A1
Human necessities

DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF

#1016
US20250186542A1
Human necessities

COMPOSITION CONTAINING PEPTIDE COMPOUND FOR USE WITH SURFACTANT

#1017
US20250186543A1
Human necessities

CYCLOSPORIN DERIVATIVES AND USES THEREOF

#1018
US20250186544A1
Human necessities

GIP/GLP1 AGONIST COMPOSITIONS

#1019
US20250186545A1
Human necessities

RECOMBINANT PROTEIN FOR ULCERATIVE COLITIS TREATMENT OR PREVENTION AND COMPOSITION FOR ULCERATIVE COLITIS TREATMENT OR PREVENTION CONTAINING THE SAME

#1020
US20250186546A1
Human necessities

Compositions and Methods to Prevent, Inhibit or Treat Autoimmune and Vascular Disease

#1021
US20250186547A1
Human necessities

Compositions and Methods for Diagnosing and Treating Intellectual Disabilities

#1022
US20250186548A1
Human necessities

METHOD FOR TREATING MYASTHENIA GRAVIS WITH TACI-FC FUSION PROTEIN

#1023
US20250186549A1
Human necessities

NOVEL FORMULATION COMPRISING MYELOID-DERIVED GROWTH FACTOR

#1024
US20250186550A1
Human necessities

PHARMACEUTICAL COMPOSITION OF IL2 MUTANT-ANTIBODY FC BLOCK FUSION PROTEIN AND USE THEREOF

#1025
US20250186551A1
Human necessities

THERAPEUTIC NUCLEIC ACID MOLECULE, MIXTURE, AND DRUG, AND USE THEREOF IN TREATING SOLID TUMOR

#1026
US20250186552A1
Human necessities

DOSAGE REGIMEN FOR PEGYLATED INTERFERON

#1027
US20250186553A1
Human necessities

Formulations of MANP and Uses Thereof

#1028
US20250186554A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1 AND ANALOGS THEREOF

#1029
US20250186555A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-2

#1030
US20250186556A1
Human necessities

COMBINATION THERAPY WITH IMMUNOMODULATORS, DYRK1A INHIBITORS, AND GLP1R AGONISTS FOR TYPE 1 DIABETES TREATMENT

#1031
US20250186557A1
Human necessities

MANUFACTURE, FORMULATION AND DOSING OF APRAGLUTIDE

#1032
US20250186558A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

#1033
US20250186559A1
Human necessities

FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE

#1034
US20250186560A1
Human necessities

ANTIVIRAL ANIMAL FEED ADDITIVE

#1035
US20250186561A1
Human necessities

BIOLOGICAL ENZYME FOR KILLING VIRUSES AND PREPARATION METHOD THEREOF

#1036
US20250186562A1
Human necessities

TARGET SUBSTRATE PROTEIN DEGRADATION PLATFORM

#1037
US20250186563A1
Human necessities

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

#1038 ✅ Patent 12,364,740 granted on 2025-07-22
US20250186564A1
Human necessities

Zonal and Targeted Methods and Uses for Treating a Post-Traumatic Stress Disorder

#1039
US20250186565A1
Human necessities

CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS

#1040
US20250186566A1
Human necessities

CELL-BASED VACCINES

#1041
US20250186567A1
Human necessities

MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#1042
US20250186568A1
Human necessities

CANCER VACCINES AND METHODS OF USE THEREOF

#1043
US20250186569A1
Human necessities

Virus-Like Particle Conjugates

#1044
US20250186570A1
Human necessities

ANTHRAX VACCINE

#1045
US20250186571A1
Human necessities

EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS

#1046
US20250186572A1
Human necessities

IMMUNOGENIC COMPOSITIONS

#1047
US20250186573A1
Human necessities

ATTENUATED MATURATION-DEFECTIVE CHLAMYDIA VACCINES

#1048
US20250186574A1
Human necessities

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RABIES VIRUS INFECTION

#1049
US20250186575A1
Human necessities

VACCINE CONSTRUCT AND USES THEREOF

#1050
US20250186576A1
Human necessities

SARS-COV-2 SUBUNIT VACCINE

#1051
US20250186577A1
Human necessities

VACCINE COMPOSITION COMPRISING AN ANTIGEN AND A TLR3 AGONIST

#1052
US20250186578A1
Human necessities

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN PREVENTING COVID-19

#1053
US20250186579A1
Human necessities

VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE

#1054
US20250186580A1
Human necessities

A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN

#1055
US20250186581A1
Human necessities

SOLANESOL VACCINE ADJUVANTS AND METHODS OF PREPARING SAME

#1056
US20250186582A1
Human necessities

METHODS FOR DETECTING AND REVERSING IMMUNE THERAPY RESISTANCE

#1057
US20250186583A1
Human necessities

FUSION PROTEIN OF CD137 ANTIBODY AND CD40L AND USE THEREOF

#1058
US20250186584A1
Human necessities

METHODS OF TREATING BILIARY TRACT CANCER USING ANTI-PD-L1 ANTIBODY IN COMBINATION WITH CHEMOTHERAPY

#1059
US20250186585A1
Human necessities

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

#1060
US20250186586A1
Human necessities

METHODS OF ISOLATING AND ENHANCING POPULATIONS OF TUMOR-REACTIVE LYMPHOCYTES

#1061
US20250186587A1
Human necessities

CD19 CAR NK CELLS FOR USE IN METHODS OF TREATING CANCER

#1062
US20250186588A1
Human necessities

IMMUNE CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND BISPECIFIC ANTIBODIES AND USES THEREOF

#1063
US20250186589A1
Human necessities

MODIFIED ALLOGENEIC CELLS AND METHODS AND COMPOSITIONS FOR THE PREPARATION THEREOF

#1064
US20250186590A1
Human necessities

RAS INHIBITORS

#1065
US20250186591A1
Human necessities

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#1066
US20250186592A1
Human necessities

TETRAZINE CONJUGATES FOR IN VIVO TARGETED DELIVERY OF A PAYLOAD

#1067
US20250186593A1
Human necessities

TARGETED DELIVERY TO BETA CELLS

#1068
US20250186594A1
Human necessities

IL-18 POLYPEPTIDES MODIFIED WITH POLYMERS

#1069
US20250186595A1
Human necessities

A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN

#1070
US20250186596A1
Human necessities

A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN

#1071
US20250186597A1
Human necessities

TARGETED IMMUNE ACTIVATION WITH IL-18 IMMUNOCYTOKINES

#1072
US20250186598A1
Human necessities

RECOMBINANT HUMAN SERUM ALBUMIN-COLLAGEN BINDING DOMAIN FUSION PROTEIN FOR TUMOR-SPECIFIC TARGETING MATRIX, AND USE THEREOF

#1073
US20250186599A1
Human necessities

BLOCK COPOLYMERS

#1074
US20250186600A1
Human necessities

EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

#1075
US20250186601A1
Human necessities

ANTIBODIES TARGETING LIV-1 AND USES THEREOF

#1076
US20250186602A1
Human necessities

HUMANIZED ANTIBODY THAT BONDS TO EVA1 PROTEIN OR FUNCTIONAL FRAGMENT THEREOF, ANTIBODY-DRUG CONJUGATE AND CHIMERIC ANTIGEN RECEPTOR

#1077
US20250186603A1
Human necessities

ANTI-GD2 ANTIBODIES, IMMUNOCONJUGATES AND THERAPEUTIC USES THEREOF

#1078
US20250186604A1
Human necessities

ANTI-PSMA ANTIBODY CONJUGATES

#1079 ✅ Patent 12,329,825 granted on 2025-06-17
US20250186605A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

#1080
US20250186606A1
Human necessities

MODULAR LINKER COMPOUND FOR TARGET-BINDING DRUG CONJUGATES

#1081
US20250186607A1
Human necessities

ONE-STEP SUPRAMOLECULAR MULTIFUNCTIONAL COATING ON PLANT VIRUS NANOPARTICLES FOR BIOIMAGING AND THERAPEUTIC APPLICATIONS

#1082
US20250186608A1
Human necessities

NANODIAMONDS AS DELIVERY PLATFORM FOR OXIME ANTIDOTES TO CENTRAL NERVOUS SYSTEM IN ORGANOPHOSPHATE POISONING

#1083
US20250186609A1
Human necessities

SIALIC-ACID LIGAND DECORATED THERAPEUTICS

#1084
US20250186610A1
Human necessities

USING DREADD FOR NEURONAL MODULATION IN TREATING NEURONAL DISEASES

#1085
US20250186611A1
Human necessities

MULTIPLEXED-TARGETED ADENOVIRUS VECTORS AND THEIR USE

#1086
US20250186612A1
Human necessities

VIRAL VECTORS ENCODING PARATHYROID HORMONE FUSIONS AND USES THEREOF IN TREATING HYPOPARATHYROIDISM

#1087
US20250186613A1
Human necessities

VIRAL VECTORS ENCODING GLP-2 RECEPTOR AGONIST FUSIONS AND USES THEREOF IN TREATING SHORT BOWEL SYNDROME

#1088
US20250186614A1
Human necessities

COMPACT DRUG RESPONSIVE DOMAINS FOR REGULATION OF FUNCTION/ABUNDANCE AND DELIVERY OF POLYPEPTIDE PAYLOADS

#1089
US20250186615A1
Human necessities

Induction of IL-15/IL-15RA Expression in Immune Cells

#1090
US20250186616A1
Human necessities

Molecular Systems and Therapies Using the Same

#1091
US20250186617A1
Human necessities

COMPOSITION FOR TREATING OR PREVENTING DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH ENDOPLASMIC RETICULUM STRESS OR ALL-TRANS-RETINAL, PROTECTING RETINAL THICKNESS, OR SUPPRESSING REDUCTION IN RETINAL THICKNESS OR PROGRESS OF REDUCTION IN RETINAL THICKNESS

#1092
US20250186618A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASES

#1093
US20250186619A1
Human necessities

ADENO-ASSOCIATED VIRAL VECTOR COMPOSITIONS AND METHODS OF PROMOTING MUSCLE REGENERATION

#1094
US20250186620A1
Human necessities

COMPOSITIONS FOR AND METHODS OF LONG-TERM INTEGRATION OF CIRCUITS USING CONNEXINS

#1095
US20250186621A1
Human necessities

MATERIALS AND METHODS FOR THE TREATMENT OF EIF2B5 MUTATIONS AND DISEASES RESULTING THEREFROM

#1096
US20250186622A1
Human necessities

METHODS FOR NEURAL REGENERATION IN VIVO AND USES THEREOF

#1097
US20250186623A1
Human necessities

EXPRESSION SYSTEM FOR THE TREATMENT OF CANCER

#1098
US20250186624A1
Human necessities

POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION

#1099
US20250186625A1
Human necessities

RECOMBINOGENIC NUCLEIC ACID STRANDS IN SITU

#1100
US20250186626A1
Human necessities

SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS

#1101
US20250186627A1
Human necessities

RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN

#1102
US20250186628A1
Human necessities

IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN-ALPHA (FAP-ALPHA)

#1103
US20250186629A1
Human necessities

GLOBULAR NANOSTRUCTURES

#1104
US20250186630A1
Human necessities

FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES

#1105
US20250186631A1
Human necessities

FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES

#1106
US20250186632A1
Human necessities

FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES

#1107
US20250186633A1
Human necessities

METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS

#1108
US20250186634A1
Human necessities

METHODS OF TREATING SMALL CELL LUNG CANCER

#1109
US20250186635A1
Human necessities

GLOBULAR NANOSTRUCTURES HAVING AN ANCHORING LAYER

#1110
US20250186636A1
Human necessities

PROCESS FOR THE PREPARATION OF STERILE PRODUCTS

#1111
US20250186637A1
Human necessities

Device for Surface Disinfection of the Input Field of Card Readers for Credit Cards, Subscriptions and Payment Cards of All Kinds

#1112
US20250186638A1
Human necessities

Method and Technique for the Focusing of UVC Light Energy to a Focused Energy Beam

#1113
US20250186639A1
Human necessities

HARD-SURFACE DISINFECTION SYSTEM

#1114
US20250186640A1 ⚡
Human necessities

FLUSHING SYSTEMS FOR SURGICAL INSTRUMENTS

#1115
US20250186641A1
Human necessities

APPARATUS AND METHOD FOR MODIFYING A SPRAYER BOTTLE INTO AN OZONATING AND IONIZING WATER SPRAYER BOTTLE AND FOR PROVIDING HUMIDIFICATION WITH OZONATED AND IONIZED WATER

#1116
US20250186642A1
Human necessities

DENTAL POD

#1117
US20250186643A1
Human necessities

NEGATIVE PRESSURE CONTAINMENT SYSTEM AND METHOD

#1118
US20250186644A1
Human necessities

MOBILE STERILIZATION APPARATUS AND METHOD FOR USING THE SAME

#1119
US20250186645A1
Human necessities

ELECTRONIC SCENTED CANDLE AND FRAGRANCE CONTAINER

#1120
US20250186646A1
Human necessities

Use of Volatile Compositions to Limit or Eliminate Perception of Fecal Malodour

#1121
US20250186647A1
Human necessities

SYSTEMS AND METHODS FOR NEUTRALIZING MATTER

#1122
US20250186648A1
Human necessities

UV EMITTING UPPER AIR DISINFECTION DEVICE

#1123
US20250186649A1
Human necessities

ULTRAVIOLET STERILIZATION DEVICE

#1124
US20250186650A1
Human necessities

AUTOMATIC CONTACT LENS CARE DEVICE

#1125
US20250186651A1
Human necessities

HYDROGEL-BASED TOPICAL WOUND DRESSING CONTAINING PROTEIN EXTRACT

#1126
US20250186652A1
Human necessities

ARTICLES AND METHODS FOR IMPROVED TISSUE HEALING

#1127
US20250186653A1
Human necessities

COMPOSITION OF ALPHA-TCP, SILICATE AND PHOSPHORYLATED AMINO ACID

#1128
US20250186654A1
Human necessities

CROSSLINKED STRUCTURAL ORTHOPEDIC BIOMATERIAL AND METHOD FOR MANUFACTURE

#1129
US20250186655A1
Human necessities

VALVE MATERIAL, METHOD FOR PREPARING SAME AND USE THEREOF

#1130
US20250186656A1
Human necessities

SHAPE MORPHING HYDROGEL ACTUATORS AND CONSTRUCTS

#1131
US20250186657A1
Human necessities

NEURONAL REPLACEMENT AND REESTABLISHMENT OF AXONAL CONNECTIONS

#1132
US20250186658A1
Human necessities

PROCESS FOR PREPARING A DRIED, SWELLABLE, SPONGY BIOLOGICAL MATERIAL FOR IMPLANTS

#1133
US20250186659A1
Human necessities

FABRICATION METHOD OF DIRECTIONAL TISSUE WITH ACOUSTIC PATTERNING OF PORE- FORMING PARTICLES

#1134
US20250186660A1
Human necessities

CATHETER COATINGS

#1135
US20250186661A1
Human necessities

LACTATION FLOW METER GAUGE, LACTATION-LATCH SENSOR DEVICE AND REMOVABLE FILTER

#1136
US20250186662A1
Human necessities

APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD

#1137
US20250186663A1
Human necessities

DIALYSIS SYSTEM INCLUDING A WATER TREATMENT DEVICE

#1138
US20250186664A1
Human necessities

BLOOD TREATMENT SYSTEMS AND METHODS

#1139
US20250186665A1
Human necessities

Conductivity Control Systems

#1140
US20250186666A1
Human necessities

SYSTEM AND METHOD OF TREATMENT FOR PREMATURE FETUS

#1141
US20250186667A1
Human necessities

Holding Means For Holding An Oxygenator And A Blood Pump

#1142
US20250186668A1
Human necessities

DEVICES AND METHODS FOR ASSESSING VASCULAR ACCESS

#1143
US20250186669A1
Human necessities

METHOD AND APPARATUS FOR CATHETER-BASED EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)

#1144
US20250186670A1
Human necessities

Systems and Methods for Treating Blood

#1145
US20250186671A1
Human necessities

Dynamic Adjustment Of Algorithms For Separation And Collection Of Blood Components

#1146
US20250186672A1
Human necessities

Nasal Device

#1147
US20250186673A1
Human necessities

SYSTEMS, METHODS AND HANDHELD PULSATILE ASPIRATION AND INJECTION DEVICES

#1148
US20250186674A1 ⚡
Human necessities

MANUAL ACTUATION OF ROBOTIC SUCTION IRRIGATORS

#1149
US20250186675A1
Human necessities

IMPROVED DRESSINGS AND SYSTEMS FOR NEGATIVE-PRESSURE WOUND THERAPY AND INSTILLATION THERAPY HAVING LOW-VOLUME MANIFOLDS AND BYPASS INSTILLATION PASSAGES

#1150
US20250186676A1
Human necessities

NEGATIVE PRESSURE WOUND THERAPY ADVISORY SYSTEM, NEGATIVE PRESSURE WOUND THERAPY METHOD AND NON-TRANSITORY COMPUTER-READABLE MEDIA

#1151
US20250186677A1
Human necessities

MEDICAL DEVICE AUDIBLE ALERTS

#1152
US20250186678A1
Human necessities

Negative Pressure Medical Device

#1153
US20250186679A1
Human necessities

PORTABLE PUMP FOR NEGATIVE PRESSURE WOUND THERAPY

#1154
US20250186680A1
Human necessities

DEVICE FOR EAR AND RELATED METHODS

#1155
US20250186681A1
Human necessities

PACKAGING FOR DRUG DELIVERY DEVICE

#1156
US20250186682A1
Human necessities

Variable Flow Control Device, System, and Method

#1157
US20250186683A1
Human necessities

PUMPING AND INSERTING MECHANISM AND RELATED AUTOMATED INJECTION SYSTEM

#1158
US20250186684A1
Human necessities

DRUG SOLUTION ADMINISTRATION DEVICE

#1159
US20250186685A1
Human necessities

FLUID TRANSFER PUMP DEVICE

#1160
US20250186686A1
Human necessities

DRUG SOLUTION ADMINISTRATION DEVICE

#1161
US20250186687A1
Human necessities

VENOCLYSIS DEVICE

#1162
US20250186688A1
Human necessities

INDWELLING ASSEMBLY

#1163
US20250186689A1
Human necessities

NEEDLE-FREE CONNECTORS

#1164
US20250186690A1
Human necessities

Devices and Methods for Providing a Bolus Dose in a Microfluidic Circuit of a Pump

#1165
US20250186691A1
Human necessities

SYSTEMS AND METHODS FOR IMPROVING OPERATION OF INFUSION PUMPS

#1166
US20250186692A1
Human necessities

PRESCRIPTION TRACKING AND VERIFICATION USING AN INTELLIGENT INJECTION DEVICE

#1167
US20250186693A1
Human necessities

MEDICAL WASTE MANAGEMENT USING AN INTELLIGENT INJECTION DEVICE

#1168
US20250186694A1
Human necessities

TRACKING MEDICATION USAGE AND SUPPLY CHAIN EVENT USING NETWORKED INTELLIGENT INJECTION DEVICES

#1169
US20250186695A1
Human necessities

SYNERGISTIC FEATURES AND FUNCTIONS RELATED TO OPERATION OF A MEDICATION DELIVERY SYSTEM AND A MEAL TRANSACTION APPLICATION

#1170
US20250186696A1
Human necessities

METHODS OF WIRELESS COMMUNICATION IN AN INFUSION PUMP SYSTEM

#1171
US20250186697A1
Human necessities

WORKPIECE CARRIER FOR AN INJECTION DEVICE

#1172
US20250186698A1
Human necessities

REMOVABLY ATTACHABLE ELECTRONIC DOSE MEASURING DEVICE FOR AN INJECTION PEN SYSTEM

#1173
US20250186699A1
Human necessities

AUTOINJECTOR

#1174
US20250186700A1
Human necessities

DEVICE FOR ADMINISTERING A MEDICINAL LIQUID BY INJECTION

#1175
US20250186701A1
Human necessities

INJECTION SYSTEM

#1176
US20250186702A1
Human necessities

SAMPLE COLLECTION CUP AND SYRINGE

#1177
US20250186703A1
Human necessities

PLUNGER ROD ASSEMBLY CONFIGURED TO REDUCE USE ERROR ASSOCIATED WITH OPERATION OF A MEDICAL DEVICE INCLUDING THE PLUNGER ROD ASSEMBLY

#1178
US20250186704A1
Human necessities

DOSE LOGGING ASSEMBLY WITH ROTATIONAL TRANSMISSION FEATURE

#1179
US20250186705A1
Human necessities

SUB-ASSEMBLY FOR A MEDICAMENT DELIVERY DEVICE

#1180
US20250186706A1
Human necessities

Treatment Apparatus and Method to Enhance Performance of Medical Needles and Sharp Instruments

#1181
US20250186707A1
Human necessities

NEEDLE HUB AND INJECTOR USING THE SAME

#1182
US20250186708A1
Human necessities

GAS TRAP DEVICE

#1183
US20250186709A1
Human necessities

DROPLET DEVICE WITH APERTURE PLATE INCLUDING DIFFERENT OPENING SIZES

#1184
US20250186710A1
Human necessities

NICOTINE DROPLET DELIVERY DEVICE

#1185
US20250186711A1
Human necessities

AEROSOL DELIVERY DEVICE WITH CONDENSING AND NON-CONDENSING VAPORIZATION

#1186
US20250186712A1
Human necessities

AEROSOL DELIVERY SYSTEM WITH HUMIDIFICATION

#1187
US20250186713A1
Human necessities

DISPOSABLE CARTRIDGES FOR ELECTROSTATIC APPLICATOR, SYSTEMS, AND METHODS THEREOF

#1188
US20250186714A1
Human necessities

VACCINE ADMINISTRATION APPARATUS AND METHOD

#1189
US20250186715A1
Human necessities

INHALER

#1190
US20250186716A1
Human necessities

MULTI-UNIT DOSE DRY POWDER INHALER AND METHODS OF USE

#1191
US20250186717A1
Human necessities

PORTABLE HOLDING CHAMBER

#1192
US20250186718A1
Human necessities

DRUG DELIVERY DEVICE WITH ELECTRONICS

#1193
US20250186719A1
Human necessities

INHALER

#1194
US20250186720A1
Human necessities

SUBSTITUTE SMOKING DEVICE COMPRISING MULTIPLE AEROSOLS AND PASSIVE AEROSOL GENERATION

#1195
US20250186721A1
Human necessities

IMPROVEMENTS RELATING TO NASAL PIECES

#1196
US20250186722A1
Human necessities

ARRANGEMENT FOR NOISE REDUCTION

#1197
US20250186723A1
Human necessities

CONTINUOUS POSITIVE AIRWAY PRESSURE CPAP DEVICE FEATURED WITH ACTIVE NOISE CANCELLATION AND METHOD THEREOF

#1198
US20250186724A1
Human necessities

METHOD AND SYSTEM FOR CONTROLLING TURBINE MOTOR OF VENTILATOR

#1199
US20250186725A1
Human necessities

CRICOTHYROTOMY DEVICE AND USES THEREOF

#1200
US20250186726A1
Human necessities

DEVICE FOR REPLACING THE ORAL TRACHEAL INTUBATION WITH NASAL TRACHEAL INTUBATION